Not recruitingISRCTN12638696

Concomitant administration of quetiapine (Seroquel®) in cognitive-behavioural therapy for refractory depression: a 12-week placebo-controlled study

Research studyAges 18–70Canada

The study in practice

Understand this study

Listed age limits: 18 years to 70 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Astra Zeneca Canada Inc.
Sponsor type: Other organization
Study type: Other
Intervention type: Other / unclear
Locations: Canada
Age range: From 18 Years to 70 Years
Official registry ID: ISRCTN12638696
Official title: Show the full official title
Concomitant administration of quetiapine (Seroquel®) in cognitive-behavioural therapy for refractory depression: a 12-week placebo-controlled study

Not recruiting

Canada

FAQ

Who is behind this study?

The study sponsor is Astra Zeneca Canada Inc.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as not recruiting.